FR2833838B1 - METHOD FOR MANUFACTURING A TABLET INCLUDING A MORPHINIC ANALGESIC AND TABLET OBTAINED - Google Patents
METHOD FOR MANUFACTURING A TABLET INCLUDING A MORPHINIC ANALGESIC AND TABLET OBTAINEDInfo
- Publication number
- FR2833838B1 FR2833838B1 FR0116704A FR0116704A FR2833838B1 FR 2833838 B1 FR2833838 B1 FR 2833838B1 FR 0116704 A FR0116704 A FR 0116704A FR 0116704 A FR0116704 A FR 0116704A FR 2833838 B1 FR2833838 B1 FR 2833838B1
- Authority
- FR
- France
- Prior art keywords
- tablet
- manufacturing
- morphinic
- analgesic
- morphinic analgesic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/5545—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having eight-membered rings not containing additional condensed or non-condensed nitrogen-containing 3-7 membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0116704A FR2833838B1 (en) | 2001-12-21 | 2001-12-21 | METHOD FOR MANUFACTURING A TABLET INCLUDING A MORPHINIC ANALGESIC AND TABLET OBTAINED |
PCT/FR2002/004488 WO2003053417A2 (en) | 2001-12-21 | 2002-12-20 | Method for making a tablet comprising a morphine type analgesic and resulting tablet |
AU2002364675A AU2002364675A1 (en) | 2001-12-21 | 2002-12-20 | Method for making a tablet comprising a morphine type analgesic and resulting tablet |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0116704A FR2833838B1 (en) | 2001-12-21 | 2001-12-21 | METHOD FOR MANUFACTURING A TABLET INCLUDING A MORPHINIC ANALGESIC AND TABLET OBTAINED |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2833838A1 FR2833838A1 (en) | 2003-06-27 |
FR2833838B1 true FR2833838B1 (en) | 2005-09-16 |
Family
ID=8870863
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR0116704A Expired - Fee Related FR2833838B1 (en) | 2001-12-21 | 2001-12-21 | METHOD FOR MANUFACTURING A TABLET INCLUDING A MORPHINIC ANALGESIC AND TABLET OBTAINED |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2002364675A1 (en) |
FR (1) | FR2833838B1 (en) |
WO (1) | WO2003053417A2 (en) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7776314B2 (en) | 2002-06-17 | 2010-08-17 | Grunenthal Gmbh | Abuse-proofed dosage system |
DE10361596A1 (en) | 2003-12-24 | 2005-09-29 | Grünenthal GmbH | Process for producing an anti-abuse dosage form |
US20070048228A1 (en) | 2003-08-06 | 2007-03-01 | Elisabeth Arkenau-Maric | Abuse-proofed dosage form |
DE10336400A1 (en) | 2003-08-06 | 2005-03-24 | Grünenthal GmbH | Anti-abuse dosage form |
US8075872B2 (en) | 2003-08-06 | 2011-12-13 | Gruenenthal Gmbh | Abuse-proofed dosage form |
DE102004032051A1 (en) | 2004-07-01 | 2006-01-19 | Grünenthal GmbH | Process for the preparation of a secured against misuse, solid dosage form |
DE102005005446A1 (en) | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Break-resistant dosage forms with sustained release |
DE102004032049A1 (en) * | 2004-07-01 | 2006-01-19 | Grünenthal GmbH | Anti-abuse, oral dosage form |
DE102005005449A1 (en) | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Process for producing an anti-abuse dosage form |
SA07280459B1 (en) | 2006-08-25 | 2011-07-20 | بيورديو فارما إل. بي. | Tamper Resistant Oral Pharmaceutical Dosage Forms Comprising an Opioid Analgesic |
TWI454288B (en) | 2008-01-25 | 2014-10-01 | Gruenenthal Chemie | Pharmaceutical dosage form |
SI2273983T1 (en) | 2008-05-09 | 2016-11-30 | Gruenenthal Gmbh | Process for the preparation of an intermediate powder formulation and a final solid dosage form under usage of a spray congealing step |
JP5667183B2 (en) | 2009-07-22 | 2015-02-12 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | Controlled release dosage form with heat melt extrusion |
JP2012533585A (en) | 2009-07-22 | 2012-12-27 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | Tamper-resistant dosage forms for oxidation-sensitive opioids |
ES2486791T3 (en) | 2010-09-02 | 2014-08-19 | Grünenthal GmbH | Tamper resistant dosage form comprising an inorganic salt |
US9636303B2 (en) | 2010-09-02 | 2017-05-02 | Gruenenthal Gmbh | Tamper resistant dosage form comprising an anionic polymer |
AR087360A1 (en) | 2011-07-29 | 2014-03-19 | Gruenenthal Gmbh | PROOF OF HANDLING TABLET PROVIDING IMMEDIATE RELEASE OF PHARMACY |
US20130028972A1 (en) | 2011-07-29 | 2013-01-31 | Grunenthal Gmbh | Tamper-resistant tablet providing immediate drug release |
BR112014019988A8 (en) | 2012-02-28 | 2017-07-11 | Gruenenthal Gmbh | BREAK-RESISTANT DOSAGE FORM COMPRISING A PHARMACOLOGICALLY ACTIVE COMPOUND AND AN ANIONIC POLYMER |
ES2692944T3 (en) | 2012-04-18 | 2018-12-05 | Grünenthal GmbH | Pharmaceutical dosage form resistant to handling and resistant to rapid discharge of the dose |
US10064945B2 (en) | 2012-05-11 | 2018-09-04 | Gruenenthal Gmbh | Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc |
WO2014191396A1 (en) | 2013-05-29 | 2014-12-04 | Grünenthal GmbH | Tamper resistant dosage form with bimodal release profile |
BR112015026549A2 (en) | 2013-05-29 | 2017-07-25 | Gruenenthal Gmbh | tamper-proof dosage form containing one or more particles |
CN105682643B (en) | 2013-07-12 | 2019-12-13 | 格吕伦塔尔有限公司 | Tamper resistant dosage form containing ethylene-vinyl acetate polymer |
CA2931553C (en) | 2013-11-26 | 2022-01-18 | Grunenthal Gmbh | Preparation of a powdery pharmaceutical composition by means of cryo-milling |
AU2015261060A1 (en) | 2014-05-12 | 2016-11-03 | Grunenthal Gmbh | Tamper resistant immediate release capsule formulation comprising Tapentadol |
AU2015266117A1 (en) | 2014-05-26 | 2016-11-24 | Grunenthal Gmbh | Multiparticles safeguarded against ethanolic dose-dumping |
MX2017013637A (en) | 2015-04-24 | 2018-03-08 | Gruenenthal Gmbh | Tamper-resistant dosage form with immediate release and resistance against solvent extraction. |
US10842750B2 (en) | 2015-09-10 | 2020-11-24 | Grünenthal GmbH | Protecting oral overdose with abuse deterrent immediate release formulations |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10014588A1 (en) * | 2000-03-27 | 2001-10-04 | Basf Ag | Sustained-release oral dosage form that floats in gastric fluid includes a blend of polyvinyl acetate and polyvinylpyrrolidone |
-
2001
- 2001-12-21 FR FR0116704A patent/FR2833838B1/en not_active Expired - Fee Related
-
2002
- 2002-12-20 AU AU2002364675A patent/AU2002364675A1/en not_active Abandoned
- 2002-12-20 WO PCT/FR2002/004488 patent/WO2003053417A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
FR2833838A1 (en) | 2003-06-27 |
WO2003053417A3 (en) | 2003-12-18 |
AU2002364675A1 (en) | 2003-07-09 |
WO2003053417A2 (en) | 2003-07-03 |
AU2002364675A8 (en) | 2003-07-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2833838B1 (en) | METHOD FOR MANUFACTURING A TABLET INCLUDING A MORPHINIC ANALGESIC AND TABLET OBTAINED | |
FR2812449B1 (en) | PLASMA DISPLAY AND METHOD FOR MANUFACTURING PLASMA DISPLAY | |
FR2825834B1 (en) | METHOD FOR MANUFACTURING A SEMICONDUCTOR DISSIVE | |
FR2847155B1 (en) | METHOD FOR MANUFACTURING A MEDICAL IMPLANT WITH ADJUSTED STRUCTURE AND IMPLANT OBTAINED THEREBY | |
BR0207423B1 (en) | "APPARATUS AND METHOD FOR SMALL COMPACTING A WELL PRODUCTION INTERVAL" | |
FR2777690B1 (en) | STRUCTURE AND METHOD FOR MANUFACTURING A CAPACITOR | |
FR2798220B1 (en) | INDUCTANCE AND MANUFACTURING METHOD | |
FR2806831B1 (en) | METHOD FOR MANUFACTURING A BIPOLAR SELF-ALIGNED DOUBLE-POLYSILICIUM TYPE BIPOLAR TRANSISTOR AND CORRESPONDING TRANSISTOR | |
FR2805331B1 (en) | MULTICHANNEL ELEMENT AND METHOD FOR MANUFACTURING SUCH AN ELEMENT | |
FR2858618B1 (en) | PROCESS AND REACTOR FOR MANUFACTURING HYDROXYMETHYLFURFURAL | |
FR2836242B1 (en) | PROCESS FOR MANUFACTURING A PROJECTION SCREEN | |
FR2860445B1 (en) | METHOD FOR MANUFACTURING A MOLD AND MOLD OBTAINED | |
FR2822597B1 (en) | MULTI-OBJECT COMMON USE CONNECTOR AND METHOD FOR MANUFACTURING THE CONNECTOR | |
FR2779747B1 (en) | METHOD FOR MANUFACTURING A KNITTED ARTICLE AND ARTICLE SO OBTAINED | |
FR2856189B1 (en) | METHOD FOR MANUFACTURING A MAGNETIC ENCODING DEVICE, AND THE DEVICE THUS OBTAINED | |
FR2822292B1 (en) | METHOD FOR MANUFACTURING A DOUBLE POLYSILICON-TYPE BIPOLAR TRANSISTOR HETEROJUNCTION BASED AND CORRESPONDING TRANSISTOR | |
FR2842137B1 (en) | METHOD FOR MANUFACTURING A BELOW BELLOW | |
FR2796577B1 (en) | PROCESS FOR MANUFACTURING A TUBULAR ELEMENT AND TUBULAR ELEMENT THUS OBTAINED | |
FR2837216B1 (en) | METHOD FOR MANUFACTURING A MOLDED ELEMENT | |
FR2827294B1 (en) | DISCONTINUOUS PROCESS FOR THE MANUFACTURE OF A POLYAMIDE | |
FR2809657B1 (en) | METHOD FOR MANUFACTURING FURNITURE ELEMENT | |
FR2808031B1 (en) | METHOD OF OPERATING A GRAVILLONNEUR AND GRAVILLONNEUR OBTAINED | |
FR2834377B1 (en) | ANTI-DIFFUSING GRID AND METHOD FOR MANUFACTURING SUCH A GRID | |
FR2806948B1 (en) | PROCESS FOR MANUFACTURING A METAL LOT | |
FR2829909B1 (en) | METHOD FOR MANUFACTURING A PREFORMED MODULE FOR A THERMOFORMED SOLE, PREFORMED MODULE AND A THERMOFORMED SOLE |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |
Effective date: 20060831 |